1:30 PM
 | 
Nov 10, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

EOC Pharma raises $32M series B

On Nov. 7, EOC Pharma Group (Shanghai, China) raised $32 million in a series B round led by new investor Taikang. Fellow new investor H&Q Asia Pacific also participated, as did existing investor Sequoia China.

EOC Pharma, a spin-off...

Read the full 172 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >